Other
IRE
IRE is an intervention with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
2(50%)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Terminated(1)
Other(1)
Detailed Status
Recruiting2
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting250%
unknown125%
terminated125%
Recent Activity
2 active trials
Showing 4 of 4
recruitingnot_applicable
IRE After Chemotherapy for Locally Advanced Pancreatic Cancer
NCT07799935
recruitingnot_applicable
IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus
NCT07799922
unknownnot_applicable
Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer
NCT04093141
terminated
Prospective Tumor Response Evaluation
NCT02787954
Clinical Trials (4)
Showing 4 of 4 trials
NCT07799935Not Applicable
IRE After Chemotherapy for Locally Advanced Pancreatic Cancer
NCT07799922Not Applicable
IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus
NCT04093141Not Applicable
Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer
NCT02787954
Prospective Tumor Response Evaluation
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4